NeOnc is the developer of a proprietary, patented platform technology that can potentially transport pharma-based therapeutics directly to the brain without the normal boundary restrictions imposed by the body’s Blood-Brain Barrier (BBB). Using NeOnc’s formulations, pharma companies that have limited success with their CNS therapeutics because of current delivery restrictions may be able to provide patients with potentially more effective treatments.
Company Details
- Employees
- 6
- Address
- 23975 Park Sorrento, Calabasas,california 91302,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neonc.com/
- Keywords
- Los Angeles.
- HQ
- Calabasas, California
Neonc Technologies Holdings Inc Nthi Questions
Neonc Technologies Holdings Inc Nthi's website is https://neonc.com/
Neonc Technologies Holdings Inc Nthi's LinkedIn profile is https://www.linkedin.com/company/neonctechnologiesholdingsinc
Neonc Technologies Holdings Inc Nthi has
6 employees.
View email and phone details for 6
employees at Neonc Technologies Holdings Inc Nthi.
Neonc Technologies Holdings Inc Nthi's industry is
Biotechnology Research
Neonc Technologies Holdings Inc Nthi's top competitors are
Biogems International, Inc.,
Mccormack Energy,
Strategic Practice Solutions, Llc.,
Glycominds, Llc,
Aqur Biosciences, Inc.,
Ampere Life Sciences, Inc.,
Polarized Capital,
Usc Stevens Center For Innovation,
Nasdaq,
Fragment Collective.
Neonc Technologies Holdings Inc Nthi's categories are Biotechnology Research
